Axillary dissection in breast cancer: When, why, how much, and for how long? Another operation soon to be extinct?

Journal of Surgical Oncology

Volumn 48, Issue 4, 1991, Pages 217-219

  Deckers, Peter J ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

adjuvant therapy; en bloc dissection; internal mammary nodes; radiation therapy

Indexed keywords

ADULT; AXILLARY LYMPH NODE; BREAST CANCER; EDITORIAL; FEMALE; HUMAN; PRIORITY JOURNAL; SURGERY;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMAN; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; PROGNOSIS;

EID: 0026332237     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.2930480402     Document Type: Editorial

References (10)

1. Breast cancer in the medial half: results of the 1978 national survey of the American College of Surgeons
2. Location of breast carcinoma and prognosis
3. Breast cancer: relationship between the size of the primary tumor and the probability of metastatic dissemination
4. Ten‐year results of the treatment of primary operable breast carcinoma
5. Cancer of the breast: size of neoplasm and prognosis
6. Pathologic findings from the National Surgical Adjuvant Project for breast cancers
7. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast
8. Detection and significance of occult axillary node metastases in patients with invasive breast cancer
9. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes
10. Ten‐year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation